Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Non-metastatic Muscle Invasive Bladder Cancer × Cystectomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 19 Urologic Neoplasms 1 Urologic Diseases 1 Urinary Bladder Diseases 1 Transitional Cell Carcinoma of the Bladder 1 Non-metastatic Muscle Invasive Bladder Cancer 1 Infiltrating Bladder Urothelial Carcinoma 1 Cone Dystrophy 3 1 Carcinoma, Transitional Cell 1 Bladder Adenocarcinoma 1

Interventions

avelumab 1 Cystectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03674424 2025-02-26

AURA

Jules Bordet Institute

Phase 2 Completed

Non-metastatic Muscle Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡